White Paper

Exploring The Dynamic Regulatory Environment Of Drug-Device Combination Products

By Diane Paskiet, Director of Scientific Affairs, West Pharmaceutical Services, Inc.

West

Prefilled syringes and injection devices are examples of drug-device combination products (DDCPs) and offer many advantages for patients and healthcare practitioners. When it comes to regulatory approval of drug-device combination products, however, a number of challenges exist. A drug-device combination product, such as a prefilled syringe or autoinjector, will have different drug and device requirements. The development of the drug together with the device is necessary to enable timely approvals. This white paper examines the dynamic regulatory environment of drug-device combination products and provides concrete steps to take to navigate regulatory complexities and decrease time to market.

VIEW THE WHITE PAPER!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

West Pharmaceutical Services, Inc.